Literature DB >> 12612866

"Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm.

Marvin A Konstam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612866     DOI: 10.1054/jcaf.2003.9

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  5 in total

1.  Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction.

Authors:  Ali Ahmed; Inmaculada B Aban; Michael T Weaver; Wilbert S Aronow; Jerome L Fleg
Journal:  Eur J Heart Fail       Date:  2005-11-28       Impact factor: 15.534

2.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

3.  Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study.

Authors:  David D McManus; Sanjiv J Shah; Mary Rose Fabi; Alisa Rosen; Mary A Whooley; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2008-12-11       Impact factor: 5.251

4.  Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Authors:  Barry R Davis; John B Kostis; Lara M Simpson; Henry R Black; William C Cushman; Paula T Einhorn; Michael A Farber; Charles E Ford; Daniel Levy; Barry M Massie; Shah Nawaz
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

5.  Modeling Pathologies of Diastolic and Systolic Heart Failure.

Authors:  M Genet; L C Lee; B Baillargeon; J M Guccione; E Kuhl
Journal:  Ann Biomed Eng       Date:  2015-06-05       Impact factor: 3.934

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.